Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UBN2 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | CLASP1 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
mRNA | NBPF9 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | TNPO2 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | CRAMP1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | DGCR8 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | MROH8 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | RP11-458D21.5 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | PHF10 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | DHPS | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |